An April 2025 study comparing pills to injections found that both offered meaningful improvements for people struggling to overcome obesity
It plays a critical role in activating genes responsible for collagen synthesis, skin tightening, and antioxidant defense
Availability of compounded semaglutide in certain doses will only remain available as an alternative to branded Wegovy as long as it remains on the FDA drug shortages list
It is especially suited for post-GLP-1 patients because medication-driven weight loss tends to be diffuse rather than localized, leaving uneven fat distribution around the full midsection
Normal adjustment symptoms These are expected and typically manageable: loose stools 1 to 3 times daily during dose escalation, mild abdominal cramping before bowel movements, increased urgency (needing to go sooner than usual), softer stool consistency without other alarming features, symptoms that correlate with recent dose increases, and gradual improvement over 2 to 4 weeks at a stable dose